All In Biotech

Drug Trial Radar · NCT07855692

The Clinical Trial of Tamibarotene for Patients With HFpEF (RELIEF Trial)

A Multicenter, Randomized, Placebo-controlled, Double-blind Clinical Trial: The Exploratory Clinical Trial to Evaluate the Efficacy and Safety of Low-dose Tamibarotene on Improving NT-proBNP in Patients With Heart Failure With Preserved Ejection Fraction (RELIEF Trial)

Last checked: Nov 20, 2026Latest source record: Nov 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

90

Planned (sponsor's estimate)

Start

Nov 5, 2026

Primary completion

May 31, 2029

Study completion Aug 31, 2029

Sponsor

Lead sponsor
Nagoya UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Oct 2, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 26 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will evaluate the effect of 12 weeks of treatment with tamibarotene compared with placebo on N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels in patients with heart failure with preserved ejection fraction (HFpEF).

Conditions

  • HFpEF - Heart Failure With Preserved Ejection Fraction

Interventions

  • TamibaroteneDrug

    Tamibarotene 4 mg is administered orally once daily after breakfast for 12 weeks.

  • PlaceboDrug

    Placebo is administered orally once daily after breakfast for 12 weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change From Baseline in serum NT-proBNPTime frame: Baseline, 4 weeks, 12 weeks, 16 weeks

Locations

4 sites in 1 country. Site status is shown where the registry gives one.

  • Juntendo University Hospital

    Tokyo, Japan · Not yet recruiting

  • Nagoya University

    Nagoya, Aichi-ken, Japan · Recruiting

  • National Center for Geriatrics and Gerontology

    Ōbu, Aichi-ken, Japan · Not yet recruiting

  • Mie University Hospital

    Tsu, Mie-ken, Japan · Not yet recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.